| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.32 | 0.1 |